Treatment of tenosynovial giant tumors with colony-stimulating factor 1 receptor kinase inhibitors: When to start? When to stop? When to restart?

IF 6.1 2区医学 Q1 ONCOLOGY

Cancer Pub Date : 2024-11-12 DOI:10.1002/cncr.35635

Jean-Yves Blay, Armelle Dufresne, François Gouin, Gualter Vaz, Mehdi Brahmi

引用次数: 0

查看原文本刊更多论文

用集落刺激因子 1 受体激酶抑制剂治疗腱鞘巨瘤：何时开始？何时停止？何时重新开始？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer 医学-肿瘤学

CiteScore

13.10

自引率

3.20%

发文量

480

审稿时长

2-3 weeks

期刊介绍： The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research